Memorial Sloane Ketterin Cancer Ctr

New York, New York 10065

0 studies enrolling now · 4 studies all time

What they study most

Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC), Advanced Gastrointestinal Stromal Tumors (GIST), Advanced NRAS/BRAFT wt Cutaneous Melanoma, Breast Cancer, Carcinoma, Renal Cell, Esophageal Squamous Cell Cancer (SCC), Head/Neck SCC, KRAS G12-mutant NSCLC, Melanoma, Metastatic Uveal Melanoma

Studies at this site

• A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas — Running, not enrolling
• Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors — Stopped early
• DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies — Stopped early
• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments — Completed